PIEZO2 expression is an independent biomarker prognostic for gastric cancer and represents a potential therapeutic target
Abstract Gastric cancer (GC) is one of the most prevalent malignant tumors of the gastrointestinal system in the globe. The effect of PIEZO2 on the immune function and pathological features of gastric cancer remains to be explored. The Online database of cancer genes and GSE54129 have been used to a...
Main Authors: | Yun-Chao Zhang, Min Yang, Cen-di Lu, Quan-Yao Li, Jin-na Shi, Jun Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-48577-5 |
Similar Items
-
PDK4 Constitutes a Novel Prognostic Biomarker and Therapeutic Target in Gastric Cancer
by: Zimu Zhang, et al.
Published: (2022-04-01) -
Identification of therapeutic targets and prognostic biomarkers in cholangiocarcinoma via WGCNA
by: Lei Xu, et al.
Published: (2022-12-01) -
RETRACTED: Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
by: Wenlong Feng, et al.
Published: (2020-05-01) -
LRRC8A Is a Promising Prognostic Biomarker and Therapeutic Target for Pancreatic Adenocarcinoma
by: Rong Xu, et al.
Published: (2022-11-01) -
DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma
by: Thale Kristin Olsen, et al.
Published: (2022-10-01)